We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ClearPoint Neuro Inc | NASDAQ:CLPT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.99 | 5.15 | 5.99 | 0 | 09:07:59 |
| | |
Per share
|
| |
Total
|
| ||||||
Public offering price
|
| | | $ | 6.5000 | | | | | $ | 15,000,011.00 | | |
Underwriting discounts and commissions(1)
|
| | | $ | 0.3014 | | | | | $ | 695,538.97 | | |
Proceeds to the Company before expenses
|
| | | $ | 6.1986 | | | | | $ | 14,304,472.03 | | |
| | | | | S-ii | | | |
| | | | | S-ii | | | |
| | | | | S-iii | | | |
| | | | | S-iii | | | |
| | | | | S-1 | | | |
| | | | | S-3 | | | |
| | | | | S-4 | | | |
| | | | | S-7 | | | |
| | | | | S-7 | | | |
| | | | | S-8 | | | |
| | | | | S-9 | | | |
| | | | | S-13 | | | |
| | | | | S-20 | | | |
| | | | | S-20 | | | |
| | | | | S-20 | | | |
| | | | | S-21 | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 8 | | | |
| | | | | 11 | | | |
| | | | | 12 | | | |
| | | | | 13 | | | |
| | | | | 20 | | | |
| | | | | 21 | | | |
| | | | | 21 | | | |
| | | | | 22 | | | |
| | | | | 22 | | |
|
Public offering price per share
|
| | | | | | | | | $ | 6.50 | | |
|
Net tangible book value per share as of September 30, 2023
|
| | | $ | 0.93 | | | | | | | | |
|
Increase in net tangible book value per share attributable to new investors
|
| | | $ | 0.44 | | | | | | | | |
|
As adjusted net tangible book value per share after this offering
|
| | | | | | | | | $ | 1.37 | | |
|
Dilution per share to new investors
|
| | | | | | | | | $ | 5.13 | | |
Underwriter
|
| |
Number of
Shares |
| |||
Lake Street Capital Markets, LLC
|
| | | | 2,307,694 | | |
Total
|
| | | | 2,307,694 | | |
| | |
Total
|
| |||||||||||||||
| | |
Per Share
|
| |
Without
Option |
| |
With Option
|
| |||||||||
Public offering price
|
| | | $ | 6.5000 | | | | | $ | 15,000,011.00 | | | | | $ | 17,250,012.00 | | |
Underwriting discount
|
| | | $ | 0.3014 | | | | | $ | 695,538.97 | | | | | $ | 799,869.79 | | |
Proceeds, before expenses and fees, to us
|
| | | $ | 6.1986 | | | | | $ | 14,304,472.03 | | | | | $ | 16,450,142.21 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 8 | | | |
| | | | 11 | | | |
| | | | 12 | | | |
| | | | 13 | | | |
| | | | 20 | | | |
| | | | 21 | | | |
| | | | 21 | | | |
| | | | 22 | | | |
| | | | 22 | | |
Exhibit 107
The prospectus to which this Exhibit 107 is attached is a final prospectus for the related offering. The maximum aggregate offering price for such offering is $17,250,012.
1 Year ClearPoint Neuro Chart |
1 Month ClearPoint Neuro Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions